6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)
Clinical trial NCT04926168 · WITHDRAWN
Trial details
- NCT number
- NCT04926168
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-01
- Primary completion
- 2025-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.